Back to Browse Journals » Clinical Ophthalmology » Volume 7

Tafluprost once daily for treatment of elevated intraocular pressure in patients with open-angle glaucoma

Authors Liu Y, Mao W

Received 11 October 2012

Accepted for publication 20 November 2012

Published 21 December 2012 Volume 2013:7 Pages 7—14

DOI http://dx.doi.org/10.2147/OPTH.S30951

Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 3

Yang Liu, Weiming Mao

Department of Cell Biology and Anatomy, North Texas Eye Research Institute, University of North Texas Health Science Center, Fort Worth, TX

Abstract: Glaucoma is a leading cause of visual loss worldwide. Current antiglaucoma therapy focuses on lowering intraocular pressure to a safe level. In recent years, prostaglandin analogs have become the first-line agents for treating open angle glaucoma. Tafluprost, which was first reported in 2003, is a novel prostaglandin analog, and has been shown to be a potent ocular hypotensive agent in a number of preclinical and clinical studies. Also, its unique preservative-free formulation helps to decrease preservative-associated ocular disorders and improve patient compliance. In this review, studies from 2003 to 2012 focusing on the structure, metabolism, efficacy, and safety of tafluprost are summarized. These studies suggested that application of tafluprost once daily is a safe and effective treatment for patients with open angle glaucoma.

Keywords: tafluprost, prostaglandin analog, glaucoma, intraocular pressure, preservative-free formulation

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] View Full Text [HTML] 

 

Readers of this article also read:

Dimensionality reduction, and function approximation of poly(lactic-co-glycolic acid) micro- and nanoparticle dissolution rate

Ojha VK, Jackowski K, Abraham A, Snášel V

International Journal of Nanomedicine 2015, 10:1119-1129

Published Date: 4 February 2015

Complications of the endovascular management of acute ischemic stroke

Gill HL, Siracuse JJ, Parrack IK, Huang ZS, Meltzer AJ

Vascular Health and Risk Management 2014, 10:675-681

Published Date: 28 November 2014

Use of electrical impedance spectroscopy to detect malignant and potentially malignant oral lesions

Murdoch C, Brown BH, Hearnden V, Speight PM, D'Apice K, Hegarty AM, Tidy JA, Healey TJ, Highfield PE, Thornhill MH

International Journal of Nanomedicine 2014, 9:4521-4532

Published Date: 23 September 2014

Increased antiparkinson efficacy of the combined administration of VEGF- and GDNF-loaded nanospheres in a partial lesion model of Parkinson’s disease

Herrán E, Requejo C, Ruiz-Ortega JA, Aristieta A, Igartua M, Bengoetxea H, Ugedo L, Pedraz JL, Lafuente JV, Hernández RM

International Journal of Nanomedicine 2014, 9:2677-2687

Published Date: 27 May 2014

Chlorotoxin-conjugated graphene oxide for targeted delivery of an anticancer drug

Wang H, Gu W, Xiao N, Ye L, Xu Q

International Journal of Nanomedicine 2014, 9:1433-1442

Published Date: 18 March 2014

Synthesis, characterization, and antimicrobial properties of copper nanoparticles

Usman MS, El Zowalaty ME, Shameli K, Zainuddin N, Salama M, Ibrahim NA

International Journal of Nanomedicine 2013, 8:4467-4479

Published Date: 21 November 2013

ESR rate can be a marker for coronary artery disease

Eghbal Eftekhaari T

Vascular Health and Risk Management 2012, 8:669-670

Published Date: 18 December 2012

Cytomegalovirus retinitis treated with valganciclovir in Wegener’s granulomatosis

Kabata Y, Takahashi G, Tsuneoka H

Clinical Ophthalmology 2012, 6:521-523

Published Date: 27 March 2012

The use of quartz crystal microbalance with dissipation (QCM-D) for studying nanoparticle-induced platelet aggregation

Santos-Martinez MJ, Inkielewicz-Stepniak I, Medina C, Rahme K, D'Arcy DM, Fox D, Holmes JD, Zhang H, Radomski MW

International Journal of Nanomedicine 2012, 7:243-255

Published Date: 13 January 2012

Validation of four automatic devices for self-measurement of blood pressure according to the international protocol of the European Society of Hypertension

Topouchian J, Agnoletti D, Blacher J, Youssef A, Ibanez I, Khabouth J, Khawaja S, Beaino L, Asmar R

Vascular Health and Risk Management 2011, 7:709-717

Published Date: 30 November 2011